{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:44:27Z","timestamp":1784231067873,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare","award":["RS-2023-00283544"],"award-info":[{"award-number":["RS-2023-00283544"]}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2020IP0041"],"award-info":[{"award-number":["2020IP0041"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2024IP0044"],"award-info":[{"award-number":["2024IP0044"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13770-025-00739-4","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:08:56Z","timestamp":1753074536000},"page":"877-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Angiopoietin-1 and Tie2-Based Dual Cell Therapy Enhances Antiangiogenic Barrier Function in a Retina-Mimetic Model for Neovascular Retinal Disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Cha Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cholong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-3727","authenticated-orcid":false,"given":"Changmo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434\u201348.","journal-title":"Lancet"},{"key":"739_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116902","volume":"236","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang Y, Xu C, Peng A, Qin H, Yao K. Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology. Biochem Pharmacol. 2025;236:116902.","journal-title":"Biochem Pharmacol"},{"key":"739_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-0716-2059-5_17","volume":"2441","author":"KR Green","year":"2022","unstructured":"Green KR, Beazley-Long N, Lynch AP, Allen CL, Bates DO, Benest AV. Quantification of angiogenesis in laser choroidal neovascularization. Methods Mol Biol. 2022;2441:223\u201331.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"739_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10792-024-03346-9","volume":"44","author":"F Yang","year":"2024","unstructured":"Yang F, Hu R. Efficacy and safety of intravitreal conbercept and triamcinolone acetonide for wet age-related macular degeneration in China: a meta-analysis. Int Ophthalmol. 2024;44:424.","journal-title":"Int Ophthalmol"},{"key":"739_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14656566.2024.2354921","volume":"25","author":"A Kumar","year":"2024","unstructured":"Kumar A, Ferro Desideri L, Ting MYL, Anguita R. Perspectives on the currently available pharmacotherapy for wet macular degeneration. Expert Opin Pharmacother. 2024;25:755\u201367.","journal-title":"Expert Opin Pharmacother"},{"key":"739_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jamaophthalmol.2019.4557","volume":"138","author":"K Mulligan","year":"2020","unstructured":"Mulligan K, Seabury SA, Dugel PU, Blim JF, Goldman DP, Humayun MS. Economic value of anti-vascular endothelial growth factor treatment for patients with wet age-related macular degeneration in the united states. JAMA Ophthalmol. 2020;138:40\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"739_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303659","volume":"13","author":"C Liu","year":"2024","unstructured":"Liu C, Su W, Jiang X, Lv Y, Kong F, Chen Q, et al. A sustainable retinal drug co-delivery for boosting therapeutic efficacy in wAMD: unveiling multifaceted evidence and synergistic mechanisms. Adv Healthc Mater. 2024;13:e2303659.","journal-title":"Adv Healthc Mater"},{"key":"739_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10632","volume":"9","author":"C Huang","year":"2024","unstructured":"Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y, et al. A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration. Bioeng Transl Med. 2024;9:e10632.","journal-title":"Bioeng Transl Med"},{"key":"739_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-023-01829-y","volume":"21","author":"W Su","year":"2023","unstructured":"Su W, Liu C, Jiang X, Lv Y, Chen Q, Shi J, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnology. 2023;21:71.","journal-title":"J Nanobiotechnology"},{"key":"739_CR10","doi-asserted-by":"publisher","first-page":"8520489","DOI":"10.1155\/2024\/8520489","volume":"2024","author":"Y Luo","year":"2024","unstructured":"Luo Y, Li C. Advances in research related to microrna for diabetic retinopathy. J Diabetes Res. 2024;2024:8520489.","journal-title":"J Diabetes Res"},{"key":"739_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12886-022-02349-3","volume":"22","author":"N Dhillon","year":"2022","unstructured":"Dhillon N, Santiago C. Management of acute proliferative diabetic retinopathy related complications during the first COVID-19 wave. BMC Ophthalmol. 2022;22:119.","journal-title":"BMC Ophthalmol"},{"key":"739_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2024.152228","volume":"127","author":"J Li","year":"2025","unstructured":"Li J, Hou H, Li J, Zhang K. Angiopoietins\/Tie2 signaling axis and its role in angiogenesis of psoriasis. Acta Histochem. 2025;127: 152228.","journal-title":"Acta Histochem"},{"key":"739_CR13","doi-asserted-by":"crossref","unstructured":"Chen-Li G, Martinez-Archer R, Coghi A, Roca JA, Rodriguez FJ, Acaba-Berrocal L, et al. Beyond VEGF: angiopoietin-tie signaling pathway in diabetic retinopathy. J Clin Med. 2024;13:2778.","DOI":"10.3390\/jcm13102778"},{"key":"739_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2021.106919","volume":"141","author":"RG Wallace","year":"2021","unstructured":"Wallace RG, Rochfort KD, Barabas P, Curtis TM, Uehara H, Ambati BK, et al. COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant. Vascul Pharmacol. 2021;141: 106919.","journal-title":"Vascul Pharmacol"},{"key":"739_CR15","doi-asserted-by":"crossref","unstructured":"Khan M, Aziz AA, Shafi NA, Abbas T, Khanani AM. Targeting angiopoietin in retinal vascular diseases: a literature review and summary of clinical trials involving faricimab. Cells. 2020.","DOI":"10.3390\/cells9081869"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/00220345231210227","volume":"103","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lin S, Liu J, Chen Q, Kang J, Zhong J, et al. Ang1\/Tie2\/VE-cadherin signaling regulates DPSCs in vascular maturation. J Dent Res. 2024;103:101\u201310.","journal-title":"J Dent Res"},{"key":"739_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13287-025-04201-z","volume":"16","author":"ZS Zhang","year":"2025","unstructured":"Zhang ZS, Yang A, Luo X, Zhou HN, Liu YY, Bao DQ, et al. Pericyte-derived extracellular vesicles improve vascular barrier function in sepsis via the Angpt1\/PI3K\/AKT pathway and pericyte recruitment: an in vivo and in vitro study. Stem Cell Res Ther. 2025;16:70.","journal-title":"Stem Cell Res Ther"},{"key":"739_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108757","volume":"113","author":"W Li","year":"2019","unstructured":"Li W, Wei D, Xie X, Liang J, Song K, Huang L. Dl-3-n-Butylphthalide regulates the Ang-1\/Ang-2\/Tie-2 signaling axis to promote neovascularization in chronic cerebral hypoperfusion. Biomed Pharmacother. 2019;113:108757.","journal-title":"Biomed Pharmacother"},{"key":"739_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov. 2017;16:635\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"739_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/iej.14181","volume":"58","author":"S Patel","year":"2025","unstructured":"Patel S, Yang E, Milne TJ, Hussaini H, Cooper PR, Friedlander LT. Angiogenic effects of Type 2 diabetes on the dental pulp. Int Endod J. 2025;58:434\u201348.","journal-title":"Int Endod J"},{"key":"739_CR21","doi-asserted-by":"publisher","first-page":"16002","DOI":"10.1038\/ncomms16002","volume":"8","author":"AV Shah","year":"2017","unstructured":"Shah AV, Birdsey GM, Peghaire C, Pitulescu ME, Dufton NP, Yang Y, et al. The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability. Nat Commun. 2017;8:16002.","journal-title":"Nat Commun"},{"key":"739_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/pathophysiology31040043","volume":"31","author":"S Saini","year":"2024","unstructured":"Saini S, Tuli HS, Saini RV, Saini AK, Sak K, Kaur D, et al. Flavonoid-mediated suppression of tumor angiogenesis: roles of Ang-Tie\/PI3K\/AKT. Pathophysiology. 2024;31:596\u2013607.","journal-title":"Pathophysiology"},{"key":"739_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000533321","volume":"60","author":"F Tang","year":"2023","unstructured":"Tang F, Huang K, Peng B, Deng W, Su N, Xu F, et al. RhoA\/ROCK signaling is involved in pathological retinal neovascularization. J Vasc Res. 2023;60:183\u201392.","journal-title":"J Vasc Res"},{"key":"739_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s44161-024-00546-5","volume":"3","author":"N Tetik-Elsherbiny","year":"2024","unstructured":"Tetik-Elsherbiny N, Elsherbiny A, Setya A, Gahn J, Tang Y, Gupta P, et al. RNF20-mediated transcriptional pausing and VEGFA splicing orchestrate vessel growth. Nat Cardiovasc Res. 2024;3:1199\u2013216.","journal-title":"Nat Cardiovasc Res"},{"key":"739_CR25","doi-asserted-by":"publisher","first-page":"109161","DOI":"10.1016\/j.isci.2024.109161","volume":"27","author":"Y Miyamura","year":"2024","unstructured":"Miyamura Y, Kamei S, Matsuo M, Yamazaki M, Usuki S, Yasunaga K, et al. FOXO1 stimulates tip cell-enriched gene expression in endothelial cells. iScience. 2024;27:109161.","journal-title":"iScience."},{"key":"739_CR26","doi-asserted-by":"publisher","first-page":"23910","DOI":"10.1074\/jbc.M702169200","volume":"282","author":"T Mammoto","year":"2007","unstructured":"Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007;282:23910\u20138.","journal-title":"J Biol Chem"},{"key":"739_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","volume":"86","author":"I Kim","year":"2000","unstructured":"Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2019-Kinase\/Akt signal transduction pathway. Circ Res. 2000;86:24\u20139.","journal-title":"Circ Res"},{"key":"739_CR28","doi-asserted-by":"crossref","unstructured":"Richter RP, Ashtekar AR, Zheng L, Pretorius D, Kaushlendra T, Sanderson RD, et al. Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress-related AMPK\/FoxO1 signaling. JCI Insight. 2022;7:e155010.","DOI":"10.1172\/jci.insight.155010"},{"issue":"2","key":"739_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCRESAHA.115.303227","volume":"115","author":"H Dharaneeswaran","year":"2014","unstructured":"Dharaneeswaran H, Abid MR, Yuan L, Dupuis D, Beeler D, Spokes KC, et al. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. Circ Res. 2014;115(2):238\u201351.","journal-title":"Circ Res"},{"key":"739_CR30","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.18632\/oncotarget.20065","volume":"8","author":"L Zhang","year":"2017","unstructured":"Zhang L, Shan Y, Ji X, Zhu M, Li C, Sun Y, et al. Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget. 2017;8:104745\u201360.","journal-title":"Oncotarget"},{"key":"739_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-cellbio-101512-122340","volume":"29","author":"T Mammoto","year":"2013","unstructured":"Mammoto T, Mammoto A, Ingber DE. Mechanobiology and developmental control. Annu Rev Cell Dev Biol. 2013;29:27\u201361.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"739_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.1189704","volume":"18","author":"C Daly","year":"2004","unstructured":"Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 2004;18(9):1060\u201371.","journal-title":"Genes Dev"},{"key":"739_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11892-016-0816-5","volume":"16","author":"PA Campochiaro","year":"2016","unstructured":"Campochiaro PA, Peters KG. Targeting Tie2 for treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2016;16:126.","journal-title":"Curr Diab Rep"},{"key":"739_CR34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101093R","volume":"36","author":"S Dasgupta","year":"2022","unstructured":"Dasgupta S, Saha A, Ganguly N, Bhuniya A, Dhar S, Guha I, et al. NLGP regulates RGS5-TGFbeta axis to promote pericyte-dependent vascular normalization during restricted tumor growth. FASEB J. 2022;36:e22268.","journal-title":"FASEB J"},{"key":"739_CR35","doi-asserted-by":"publisher","first-page":"2435478","DOI":"10.1080\/19420862.2024.2435478","volume":"16","author":"B Hwang","year":"2024","unstructured":"Hwang B, Jeon MY, Jang JH, Cho YL, Lee DG, Min JK, et al. Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemia. MAbs. 2024;16:2435478.","journal-title":"MAbs"},{"key":"739_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12967-024-05441-y","volume":"22","author":"L Sha","year":"2024","unstructured":"Sha L, Zhao Y, Li S, Wei D, Tao Y, Wang Y. Insights to Ang\/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases. J Transl Med. 2024;22:898.","journal-title":"J Transl Med"},{"key":"739_CR37","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/14656566.2019.1636031","volume":"20","author":"H Al-Khersan","year":"2019","unstructured":"Al-Khersan H, Hussain RM, Ciulla TA, Dugel PU. Innovative therapies for neovascular age-related macular degeneration. Expert Opin Pharmacother. 2019;20:1879\u201391.","journal-title":"Expert Opin Pharmacother"},{"key":"739_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100077","volume":"13","author":"JB Jonas","year":"2024","unstructured":"Jonas JB. Diabetic retinopathy. Asia Pac J Ophthalmol (Phila). 2024;13:100077.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"739_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41591-024-03454-0","volume":"31","author":"C Arnold","year":"2025","unstructured":"Arnold C. Gene therapy targets the retina to treat eye disease. Nat Med. 2025;31:2\u20133.","journal-title":"Nat Med"},{"key":"739_CR40","doi-asserted-by":"crossref","unstructured":"Chekuri A. Combinatorial gene therapy for gyrate atrophy of the choroid and retina. Mol Ther. 2025;33:2955-56.","DOI":"10.1016\/j.ymthe.2025.03.063"},{"key":"739_CR41","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/cpt.3230","volume":"115","author":"JL Ford","year":"2024","unstructured":"Ford JL, Karatza E, Mody H, Nagaraja Shastri P, Khajeh Pour S, Yang TY, et al. Clinical pharmacology perspective on development of adeno-associated virus vector-based retina gene therapy. Clin Pharmacol Ther. 2024;115:1212\u201332.","journal-title":"Clin Pharmacol Ther"},{"key":"739_CR42","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.gt.3302571","volume":"12","author":"K Kashofer","year":"2005","unstructured":"Kashofer K, Bonnet D. Gene therapy progress and prospects: stem cell plasticity. Gene Ther. 2005;12:1229\u201334.","journal-title":"Gene Ther"},{"key":"739_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010611","volume":"5","author":"JY Qin","year":"2010","unstructured":"Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, Ren BZ, et al. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS One. 2010;5:e10611.","journal-title":"PLoS ONE"},{"key":"739_CR44","first-page":"3603","volume":"62","author":"M Studeny","year":"2002","unstructured":"Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62:3603\u20138.","journal-title":"Cancer Res"},{"key":"739_CR45","doi-asserted-by":"publisher","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","volume":"5","author":"D Dalkara","year":"2013","unstructured":"Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, et al. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5:189ra76. https:\/\/doi.org\/10.1126\/scitranslmed.3005708.","journal-title":"Sci Transl Med."},{"key":"739_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101366","volume":"32","author":"J Shim","year":"2024","unstructured":"Shim J, Kim Y, Bak J, Shin S, Lee K, Hwang YH, et al. Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration. Mol Ther Methods Clin Dev. 2024;32:101366. https:\/\/doi.org\/10.1016\/j.omtm.2024.101366.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"739_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","volume":"376","author":"JA Ribeil","year":"2017","unstructured":"Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. Gene therapy in a patient with sickle cell disease. N Engl J Med. 2017;376:848\u201355. https:\/\/doi.org\/10.1056\/NEJMoa1609677.","journal-title":"N Engl J Med"},{"key":"739_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.molmed.2024.12.001","volume":"31","author":"G Hardouin","year":"2025","unstructured":"Hardouin G, Miccio A, Brusson M. Gene therapy for beta-thalassemia: current and future options. Trends Mol Med. 2025;31:344\u201358. https:\/\/doi.org\/10.1016\/j.molmed.2024.12.001.","journal-title":"Trends Mol Med"},{"key":"739_CR49","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1158\/1078-0432.CCR-22-0164","volume":"28","author":"C Monfrini","year":"2022","unstructured":"Monfrini C, Stella F, Aragona V, Magni M, Ljevar S, Vella C, et al. Phenotypic composition of commercial Anti-CD19 CAR T cells affects in vivo expansion and disease response in patients with large B-cell lymphoma. Clin Cancer Res. 2022;28:3378\u201386.","journal-title":"Clin Cancer Res"},{"key":"739_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nri.2017.100","volume":"17","author":"I Spadoni","year":"2017","unstructured":"Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol. 2017;17:761\u201373.","journal-title":"Nat Rev Immunol"},{"key":"739_CR51","doi-asserted-by":"crossref","unstructured":"Caporarello N, D\u2019Angeli F, Cambria MT, Candido S, Giallongo C, Salmeri M, et al. Pericytes in microvessels: From \u201cmural\u201d function to brain and retina regeneration. Int J Mol Sci. 2019;20:6351.","DOI":"10.3390\/ijms20246351"},{"key":"739_CR52","doi-asserted-by":"publisher","first-page":"1380059","DOI":"10.3389\/fcell.2024.1380059","volume":"12","author":"Y Lu","year":"2024","unstructured":"Lu Y, Tian H, Peng H, Wang Q, Bunnell BA, Bazan NG, et al. Novel lipid mediator 7S,14R-docosahexaenoic acid: biogenesis and harnessing mesenchymal stem cells to ameliorate diabetic mellitus and retinal pericyte loss. Front Cell Dev Biol. 2024;12:1380059.","journal-title":"Front Cell Dev Biol"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-025-00739-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:59:28Z","timestamp":1757260768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-025-00739-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s13770-025-00739-4","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no animal experiments carried out for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no conflicts of interest related to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}